Maryville University Nursing 615 Exam 3
Exam Coverage
The exam coverage includes advanced nursing concepts assessed in
Maryville University NURS 615 - Advanced Nursing Practice Exam 3. It
focuses on the assessment, diagnosis, and management of complex
adult and older adult patients, including acute and chronic conditions
affecting major body systems. The exam also evaluates understanding
of pharmacologic and non-pharmacologic therapies, evidence-based
interventions, clinical decision-making, patient safety, and care
prioritization. Emphasis is placed on applying advanced nursing
knowledge, critical thinking, and clinical judgment to ensure safe,
effective, and patient-centered care in diverse healthcare settings.
,Low-dose colchine
1.2 mg at first sign of flare, followed by 0.6 mg one hour later for a
total dose of 1.8 mg.
High-dose colchine
1.2 mg followed by 0.6 mg every 4-6 hours totaling 4.8 mg.
Gout
BUN, creatinine, and creatinine clearance should be monitored in the
treatment of this disease
,Colchine
This medication can cause severe diarrhea, nausea, vomiting,
abdominal pain
Febuxostat (Uloric)
When prescribing this medication, patients should be taught that gout
may worsen with therapy before it improves
, Corticosteroids
These medications can cause the following adverse effects if taken for
six months or more: Osteoporosis and poor diabetic control. Patients
should report black, tarry stools or abdominal pain.
Corticosteroids
These medications should be tapered to avoid recurrent activity of the
underlying disease and possible cortisol deficiency resulting from the
hypothalamic-pituitary-adrenal axis suppression during the period of
steroid therapy.
Exam Coverage
The exam coverage includes advanced nursing concepts assessed in
Maryville University NURS 615 - Advanced Nursing Practice Exam 3. It
focuses on the assessment, diagnosis, and management of complex
adult and older adult patients, including acute and chronic conditions
affecting major body systems. The exam also evaluates understanding
of pharmacologic and non-pharmacologic therapies, evidence-based
interventions, clinical decision-making, patient safety, and care
prioritization. Emphasis is placed on applying advanced nursing
knowledge, critical thinking, and clinical judgment to ensure safe,
effective, and patient-centered care in diverse healthcare settings.
,Low-dose colchine
1.2 mg at first sign of flare, followed by 0.6 mg one hour later for a
total dose of 1.8 mg.
High-dose colchine
1.2 mg followed by 0.6 mg every 4-6 hours totaling 4.8 mg.
Gout
BUN, creatinine, and creatinine clearance should be monitored in the
treatment of this disease
,Colchine
This medication can cause severe diarrhea, nausea, vomiting,
abdominal pain
Febuxostat (Uloric)
When prescribing this medication, patients should be taught that gout
may worsen with therapy before it improves
, Corticosteroids
These medications can cause the following adverse effects if taken for
six months or more: Osteoporosis and poor diabetic control. Patients
should report black, tarry stools or abdominal pain.
Corticosteroids
These medications should be tapered to avoid recurrent activity of the
underlying disease and possible cortisol deficiency resulting from the
hypothalamic-pituitary-adrenal axis suppression during the period of
steroid therapy.
